| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/27/2005 | US20050019406 Mixing ribavirin with excipient; pelletization; coating with material that reduces dissolution rate in water; sustained release, free-flowing |
| 01/27/2005 | US20050019399 Oral administering; mixture of amorphous drug and polymer; carvedilol |
| 01/27/2005 | US20050019396 formed by mixing metal salts with the aqueous solutions, then mixing with bases to increase the pH of the aqueous solution and forming suspensions of antibiotic metal complex, and drying the suspension by dry granulation |
| 01/27/2005 | US20050019395 Formulations of amlodipine maleate |
| 01/27/2005 | US20050019389 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
| 01/27/2005 | US20050019387 Therapeutically effective amount of liposomal entrapped irinotecan also comprising cardiolipin, and a pharmaceutically acceptable exipient, wherein at least a portion of irinotecan is complexed with cardiolipin; use in treating proliferative diseases such as cancer |
| 01/27/2005 | US20050019386 In mixture of membrane-forming amphiphiles subjected to high pressure homogenization or ultrasound; contain immunomodulator, cyclosporin, and/or at least one cytokine or polyethylene glycol-cytokines |
| 01/27/2005 | US20050019383 Adhesive surface with indentations; second component being separated by a cup shaped metal foil barrier layer with a rim extending into a flange; wound healing agents; topical |
| 01/27/2005 | US20050019382 Continuous production of solvent-free and mastication-free pressure senstive adhesive styrene block copolymer (SBC); supplying, compounding, homogenizing |
| 01/27/2005 | US20050019378 Transdermal drug delivery system of strychnine, brucine, securinine and their salts |
| 01/27/2005 | US20050019377 Dietary fiber delivery system |
| 01/27/2005 | US20050019376 Containing at least one active ingredient and a confectionery composition such as fat, amorphous sugar glass, or fondant; polarized light transmission; especially for pediatric and geriatric applications |
| 01/27/2005 | US20050019375 Consumable farinaceous food comprising alpha -cyclodextrin and fat having same amounts of calories and cholesterol; reduced bioavailability, increased high density lipoproteins |
| 01/27/2005 | US20050019374 Plasticizer, film former, bulking agent, and pH controlling agent; |
| 01/27/2005 | US20050019371 Controlled release bioactive agent delivery device |
| 01/27/2005 | US20050019369 making a suture by modifying an aqueous suspension of a nucleic acid, e.g., by capping, crosslinking, methylation, ethylation, or attachment of a protein, to form a viscous gel, which is extruded to form a filament; optionally adding a biodegradable polymer |
| 01/27/2005 | US20050019366 Drug-coated stents and methods of use therefor |
| 01/27/2005 | US20050019360 Using mixture of oil and brines |
| 01/27/2005 | US20050019355 Topical applying mixture containing alkyl ester of lactic acid; bactericide for skins |
| 01/27/2005 | US20050019354 Topical benfotiamine treatments |
| 01/27/2005 | US20050019322 Treatment of central nervous system diseases by antibodies against glatiramer acetate |
| 01/27/2005 | US20050019319 aspirin, magnesium, and nattokinase, and either niacin or nitroglycerine, especially in the form of a chewable tablet, nasal spray, or suppository |
| 01/27/2005 | US20050019314 Method and compositions for treating respiratory pathologies |
| 01/27/2005 | US20050019313 Genetic engineering; supplying stem cells; genes code cytosine deaminase; central nervous system tumors |
| 01/27/2005 | US20050019307 Therapy gene against mammary gland cancer; transcription control ; Dna |
| 01/27/2005 | US20050019304 Novel human mage-like protein |
| 01/27/2005 | US20050019303 Biodegradable copolymer, and polymeric micelle composition containing the same |
| 01/27/2005 | US20050019297 Protein derived composition for skin care using spider silk protein or an analog with adjuvants |
| 01/27/2005 | US20050019274 Biofilm removing agent for removing a biofilm |
| 01/27/2005 | US20050019271 Glycopyrrolate in sustained releae form; antimuscarinic agents |
| 01/27/2005 | US20050019264 Imaging tissue with contrast agent such as Rose Bengal; medical diagnosis |
| 01/27/2005 | US20050016391 Dietary fiber delivery system |
| 01/27/2005 | DE10331350A1 Inhalation powder useful for treating respiratory diseases comprises a 9,9-dimethyl-7-(2,2-diphenylpropionyloxy)-3-oxa-9-azatricyclononane salt and a finely divided excipient |
| 01/27/2005 | DE10328260A1 Flupirtine-Präparat Flupirtine preparation |
| 01/27/2005 | DE10304590A1 Use of a medicament comprising Agni casti fructus, Cimicifugae racemosae rhizoma and D-alpha-tocopherol for treating climacteric disorders involving impaired libido |
| 01/27/2005 | DE102004033643A1 Montageanordnung und zugehöriges Verfahren für Motorradsitze Mounting assembly and associated method for motorcycle seats |
| 01/27/2005 | CA2851309A1 Compounds and methods for delivery of prostacyclin analogs |
| 01/27/2005 | CA2800212A1 Histone deacetylase inhibitors and methods of use thereof |
| 01/27/2005 | CA2771944A1 Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
| 01/27/2005 | CA2736406A1 Compositions comprising diethanolamine salts of trepostinil in the treatment of pulmonary hypertension and other cardiovascular diseases |
| 01/27/2005 | CA2573951A1 Spiro compounds and methods for the modulation of chemokine receptor activity |
| 01/27/2005 | CA2534095A1 Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicaments |
| 01/27/2005 | CA2533314A1 Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions |
| 01/27/2005 | CA2533177A1 Treatment of male sexual dysfunction |
| 01/27/2005 | CA2533100A1 Aryl fused azapolycyclic compounds |
| 01/27/2005 | CA2533084A1 Liposomes containing phosphate glycerol groups for treating acute inflammatory condition |
| 01/27/2005 | CA2532806A1 Medicinal composition |
| 01/27/2005 | CA2532805A1 Pharmaceutical composition |
| 01/27/2005 | CA2532789A1 Methods and compositions for controlling ectoparasites |
| 01/27/2005 | CA2532725A1 Novel fusidic acid derivatives |
| 01/27/2005 | CA2532485A1 Tablets containing ambroxol |
| 01/27/2005 | CA2532352A1 Methods and pharmaceutical compositions for healing wounds |
| 01/27/2005 | CA2532316A1 Pyrazolines as par-1 antagonists for treatment of cardiovascular diseases |
| 01/27/2005 | CA2532313A1 Medicament for treatment of dermal pigmentation |
| 01/27/2005 | CA2532309A1 Ambroxol for treating acute pains |
| 01/27/2005 | CA2532308A1 Ambroxol for treating epilepsy |
| 01/27/2005 | CA2532304A1 Ambroxol for treating tinnitus |
| 01/27/2005 | CA2532301A1 Ambroxol for treating chronic nociceptive pains |
| 01/27/2005 | CA2532252A1 Treatment of sexual dysfunction |
| 01/27/2005 | CA2532229A1 Use of parthenolide derivatives as antileukemic and cytotoxic agents |
| 01/27/2005 | CA2532203A1 Method of diagnosis and treatment for asthma based on haplotype association |
| 01/27/2005 | CA2532152A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 01/27/2005 | CA2532122A1 Substituted tetrahydro-1h-pyrazolo[3,4-c]pyridines, compositions containing same and use |
| 01/27/2005 | CA2532093A1 Solid formulation |
| 01/27/2005 | CA2532078A1 Naphthylene derivatives as cytochrome p450 inhibitors |
| 01/27/2005 | CA2532057A1 Novel azaheterocyclic amides useful for treating pain |
| 01/27/2005 | CA2531817A1 Kappa agonists, especially for the treatment and/or prophylaxis of irritable bowel syndrome |
| 01/27/2005 | CA2531692A1 Hexameric porphobilinogen synthase as a target for the development of antibiotics and herbicides |
| 01/27/2005 | CA2531619A1 Biaryl piperazinyl-pyridine analogues |
| 01/27/2005 | CA2531596A1 Fluorocombretastatin and derivatives thereof |
| 01/27/2005 | CA2531535A1 Substituted quinolin-4-ylamine analogues |
| 01/27/2005 | CA2531508A1 Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 01/27/2005 | CA2531507A1 Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 01/27/2005 | CA2531401A1 Substituted heterocyclic diarylamine analogues |
| 01/27/2005 | CA2531389A1 Combretastatin derivatives with cytotoxic action |
| 01/27/2005 | CA2531343A1 Enema preparation |
| 01/27/2005 | CA2531069A1 Inhibition of syk kinase expression |
| 01/27/2005 | CA2530175A1 New n-hydroxy-4-(3-phenyl-5-methyl-isoxazole-4-yl)-benzenesulfonamide solvates |
| 01/27/2005 | CA2529790A1 Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| 01/27/2005 | CA2529193A1 Nicotine addiction reducing heteroaryl fused azapolycyclic compounds |
| 01/27/2005 | CA2528774A1 Small molecule toll-like receptor (tlr) antagonists |
| 01/27/2005 | CA2528596A1 Lincomycin derivatives possessing antibacterial activity |
| 01/27/2005 | CA2528372A1 Inhibition of apoptosis-specific elf-5a ("eif-5a1") with antisense oligonucleotides and sirnas as anti-inflammatory therapeutics |
| 01/27/2005 | CA2525949A1 Transgenic cells expressing proteins involved in fatty acid biosynthesis |
| 01/27/2005 | CA2516652A1 System for external control of oncolytic virus replication |
| 01/27/2005 | CA2495564A1 Pharmaceutical compositions |
| 01/26/2005 | EP1500702A1 APO-2LI and APO-3 apoptosis polypeptides from the TNFR1 familiy |
| 01/26/2005 | EP1500658A1 Novel thiol derivative, process for producing the same and use thereof |
| 01/26/2005 | EP1500657A1 Substituted pyrazoles as P38 kinase inhibitors |
| 01/26/2005 | EP1500656A1 Biguanide derivative and therapeutic agent for diabetes containing the same |
| 01/26/2005 | EP1500655A1 New methionine aminopeptidase inhibitor |
| 01/26/2005 | EP1500654A1 Benzoxazinone derivatives, the preparation and use thereof as medicaments |
| 01/26/2005 | EP1500652A1 Quinazoline derivative and medicine |
| 01/26/2005 | EP1500643A1 Benzamide derivatives |
| 01/26/2005 | EP1500403A1 Preventive/remedy for diabetes |
| 01/26/2005 | EP1500402A1 Cell death inhibitor |
| 01/26/2005 | EP1500401A1 Drugs for treating vascular diseases |
| 01/26/2005 | EP1500396A1 Reboxetine for treating migraine headaches |
| 01/26/2005 | EP1500395A1 Reboxetine for treating fibromyalgia and other somatoform disorders |
| 01/26/2005 | EP1500394A1 Pharmaceutical compositions comprising ascorbic acid or the treatment of fungal superinfections and fungal recurrences |